Strains Vancomycin resistant Enterococcus faecium, vanA type, was kindly supplied by Dr. K. Hiramatsu of Juntendo University, Tokyo. S. aureus 209P and E. coli JCM5491 (ATCC25922) were standard strains in our laboratories.
Time-Kill Curve Assay Growth inhibition of S. aureus 209P by dipropofol was measured with Trypticase soy broth (TSB). In 49 ml of the medium, 0.5 ml of a stationary culture of S. aureus 209P was added, and the medium was incubated at 37°C with shaking. After 0, 2, 4, 6, 8, and 10 h of incubation, dipropofol (10 mg/ml) was added. A 1 ml portion of the culture was sampled at 60-min intervals. The turbidity of the culture was measured at 600 nm with a Hitachi 220A spectrophotometer (Hitachi Seisakusho Co. Ltd., Japan). 8) Assay for Syntheses of Cellular Macromolecules S. aureus 209P, cultivated in TSB overnight at 37°C, was harvested, and washed with fresh medium by centrifugation at 3000 rpm for 15 min at 4°C. The bacterial cells were suspended at 2-3ϫ10 5 cells in casamino acid medium (L-cysteine-HCl 50 mg/ml, KH 2 PO 4 4.5 mg/l, sodium citrate 3.5 g/l, dextrose 2.5 g/l, MgSO 4 40 mg/l, thiamine-HCl 10 The mode of action of dipropofol and its antibacterial activity in combination with other antibiotics against Gram-positive and -negative bacteria were investigated. Dipropofol showed a bactericidal effect against Staphylococcus aureus 209P, and inhibited the incorporations of mg/ml, niacinamide 10 mg/ml and casein acid hydrolysate; Vitamin free (CAA) 100 mg/l). In the incorporation experiments the cell suspension was incubated in a medium containing dipropofol (2 mg/ml) and a radioactive substrate at 0.2 mCi/ml of [methyl-
Samples taken at 30-min intervals were placed into an equal volume of 0.2 mM NaN 3 -saline, and acid-precipitable counts were collected on Whatman GF/C glass fiber disks. After washing with 0.2 mM NaN 3 -saline and then with ethyl ether, the disks were immersed in an organic counting scintillant and counted using a liquid scintillation system LSC-3500 (Aloka Co. Japan).
9)
B. subtilis PCI219 was cultivated in Davis minimal medium (K 2 HPO 4 7 g/l, KH 2 PO 4 2 g/l, MgSO 4 0.1 g/l, (NH 4 ) 2 SO 4 1 g/l, sodium citrate 0.5 g/l and glucose 2 g/l) for 18 h at 37°C, and the cells were harvested and then washed by centrifugation. Radioactivity was measured by the method mentioned above.
where A represents cmp/ml.
Combination Study and Synergy Determination The in vitro combinational effect of dipropofol with other antibiotics was examined by the checkerboard titration method. Overnight cultures of test strains, grown in 10 ml of MuellerHinton broth at 37°C, were diluted 10 3 -fold with fresh Mueller-Hinton broth, followed by the addition of about 5ϫ10 4 CFU onto 20-ml Mueller-Hinton agar layers which contained dipropofol (0.39 mg/ml) and other antibiotics at concentrations ranging from 0 to 100 mg/ml. After 18 h of incubation at 37°C, the minimum inhibitory concentrations (MICs) in every combination were determined according to the method of the Japan Society of Chemotherapy.
10) The fractional inhibitory concentration (FIC) for each component was calculated based on the following formula: FIC indexϭ (MIC of drug A, tested in combination)/(MIC of drug A, tested alone)ϩ(MIC of drug B, tested in combination)/(MIC of drug B, tested alone). The interaction was defined as synergistic if the FIC index was Ͻ0.5, additive if the FIC index was Ͼ0.5 to 4, and antagonistic if the FIC index was Ͼ4.
11) RESULTS AND DISCUSSION
In order to determine whether dipropofol acts bacteriostatically or bactericidally, the following experiments were carried out using S. aureus 209P as a test organism by the turbidimetric method. Dipropofol (10 mg/ml, 5ϫMIC) was added to the medium during the logarithmic growth phase. The turbidity (optical density value) was decreased by the addition of dipropofol and the reaction was determined to be bactericidal (Fig. 2) .
Successively, the effect of dipropofol (2 mg/ml, MIC of S. aureus) 6) on the syntheses of biomacromolecules was tested with S. aureus 209P and B. subtilis PCI219. 9) As shown in Fig. 3 , the incorporation of 3 H-thymidine, a precursor of DNA synthesis, was inhibited about 40% and 20% in S. aureus and B. subtilis, respectively, after 60 min and the incorporation 3 H-uridine, a precursor of RNA synthesis, was depressed about 50% in both strains. From these results, it was concluded nucleic acid synthesis could not be the primary target of dipropofol. On the other hand, the incorporation of 3 H-leucine, which is a precursor of protein, was markedly decreased 30 min and 60 min in S. aureus and B. subtilis, respectively, after the addition of dipropofol (2 mg/ml). In addition, dipropofol blocked the incorporation of glutamate within 30 min and 60 min of addition in S. aureus and B. subtilis, respectively. Dipropofol did not the direct chemical reaction with the glutamate (data not shown). These results indicated that the mechanism of action of dipropofol was mediated by the inhibition of protein synthesis or amino acid incorporation. However, glutamate is an essential amino acid for the biosynthesis of several amino acids such as glutamine, arginine, proline, asparagine, aspartic acid, isoleucine and lysine, and it is a constituent of peptidoglycan, and it participates in nucleic acid biosynthesis. However, more detailed studies and discussion are needed in order to determine the precise mode of action of dipropofol.
Based on the discussion above, a mode of action could be hypothesized for dipropofol, which is a dimeric phenol compound having strong antibacterial and antioxidant activities, 6, 7) and some synergistic action could be expected with other antibiotic substances. The data were analyzed using the FIC (fractional inhibitory concentration) index (FIC index was Ͻ0.5).
11) The FIC index is the most frequently used method to determine interactions between antimicrobial drugs. In subsequent experiments, the combined effects between dipropofol and nine other antibiotics (carbenicillin, ampicillin, vancomycin, kanamycin, norfloxacin, erythromycin, tetracycline, rifampicin, and chloramphenicol) were examined. As shown in Table 1 , a synergistic effect between incorporation rate (%) (control) (control sample) The MIC value of rifampicin decreased from 0.78 mg/ml to Ͻ0.005 mg/ml in combination with dipropofol (0.39 mg/ml, 1/4ϫMIC) (FIC index: Ͻ0.26). The synergism against VRE (vanA type) was only confirmed in the combination between dipropofol and rifampicin, and the MIC value of rifampicin was decreased from 0.39 mg/ml to Ͻ0.005 mg/ml in combination with dipropofol (0.39 mg/ml, 1/4ϫMIC) (FIC index: Ͻ0.27). However, no synergistic effect was observed in E. coli JCM5491, which is the bacterium recommended to validate control of the sensitivity test, 12) between dipropofol and the nine antibiotics. It appears that dipropofol has a different biochemical target than rifampicin (an inhibitor of RNA polymerase), 13) and inhibits the growth of S. aureus strain synergistically. No positive synergistic activity was observed with other seven antibiotics, when used carbenicillin, ampicillin and vancomycin (inhibitors of cell wall biosynthesis), 14, 15) norfloxacin (an inhibitor of DNA gyrase), 16) and kanamycin (an inhibitor of protein synthesis), 17) erythromycin, tetracycline and chloramphenicol (inhibitors of protein synthesis different from kanamycin). [18] [19] [20] However, whether the inhibition of protein synthesis or amino acid incorporation by dipropofol is the primary site of action or a secondary one remains a problem. In the present study, the combination of dipropofol and rifampicin to treat VRE highlights novel drug targets and has importance in the design of new therapeutic regimes against resistant pathogens.
In summary, dipropofol is a new type antibiotic with bactericidal activity against Gram-positive strains. The mechanism of action of dipropofol appears to be mediated by its inhibition of protein synthesis or amino acid incorporation. Also, the action of dipropofol is synergistic when used in combination with rifampicin against VRE. The details of the mechanism of action are currently being studied using a cell free enzyme system and at the gene level. 
